200 related articles for article (PubMed ID: 31911370)
1. An interobserver reproducibility analysis of size-set semiautomatic counting for Ki67 assessment in breast cancer.
Wang YX; Wang YY; Yang CG; Bu H; Yang WT; Wang L; Xu WM; Zhao XL; Zhao WX; Li L; Song SL; Yang JL
Breast; 2020 Feb; 49():225-232. PubMed ID: 31911370
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.
Zhong F; Bi R; Yu B; Yang F; Yang W; Shui R
PLoS One; 2016; 11(2):e0150505. PubMed ID: 26928407
[TBL] [Abstract][Full Text] [Related]
3. An interobserver reproducibility analysis of Ki67 visual assessment in breast cancer.
Shui R; Yu B; Bi R; Yang F; Yang W
PLoS One; 2015; 10(5):e0125131. PubMed ID: 25932921
[TBL] [Abstract][Full Text] [Related]
4. Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study.
Mikami Y; Ueno T; Yoshimura K; Tsuda H; Kurosumi M; Masuda S; Horii R; Toi M; Sasano H
Cancer Sci; 2013 Nov; 104(11):1539-43. PubMed ID: 23905924
[TBL] [Abstract][Full Text] [Related]
5. Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.
Hida AI; Bando K; Sugita A; Maeda T; Ueda N; Matsukage S; Nakanishi M; Kito K; Miyazaki T; Ohtsuki Y; Oshiro Y; Inoue H; Kawaguchi H; Yamashita N; Aogi K; Moriya T
J Clin Pathol; 2015 May; 68(5):356-61. PubMed ID: 25673730
[TBL] [Abstract][Full Text] [Related]
6. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
[TBL] [Abstract][Full Text] [Related]
7. Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer.
Serna G; Simonetti S; Fasani R; Pagliuca F; Guardia X; Gallego P; Jimenez J; Peg V; Saura C; Eppenberger-Castori S; Ramon Y Cajal S; Terracciano L; Nuciforo P
Breast; 2020 Oct; 53():102-110. PubMed ID: 32707454
[TBL] [Abstract][Full Text] [Related]
8. [Intraobserver reproducibility of Ki-67 assessment of breast cancers based on digital slide].
Wang YY; Wang T; Yu H; Xu WM; Yu T; Song SL; Cui J; Yang JL
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1163-1168. PubMed ID: 33152823
[No Abstract] [Full Text] [Related]
9. Visual assessment of Ki67 at a glance is an easy method to exclude many luminal-type breast cancers from counting 1000 cells.
Hida AI; Oshiro Y; Inoue H; Kawaguchi H; Yamashita N; Moriya T
Breast Cancer; 2015 Mar; 22(2):129-34. PubMed ID: 23543399
[TBL] [Abstract][Full Text] [Related]
10. Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer.
Thomas S; Kabir M; Butcher BE; Chou S; Mahajan H; Farshid G; Balleine R; Pathmanathan N
Breast Cancer Res Treat; 2021 Aug; 188(3):729-737. PubMed ID: 33751322
[TBL] [Abstract][Full Text] [Related]
11. Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining.
Røge R; Riber-Hansen R; Nielsen S; Vyberg M
Breast Cancer Res Treat; 2016 Jul; 158(1):11-19. PubMed ID: 27283833
[TBL] [Abstract][Full Text] [Related]
12. Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.
Leung SCY; Nielsen TO; Zabaglo LA; Arun I; Badve SS; Bane AL; Bartlett JMS; Borgquist S; Chang MC; Dodson A; Ehinger A; Fineberg S; Focke CM; Gao D; Gown AM; Gutierrez C; Hugh JC; Kos Z; Laenkholm AV; Mastropasqua MG; Moriya T; Nofech-Mozes S; Osborne CK; Penault-Llorca FM; Piper T; Sakatani T; Salgado R; Starczynski J; Sugie T; van der Vegt B; Viale G; Hayes DF; McShane LM; Dowsett M;
Histopathology; 2019 Aug; 75(2):225-235. PubMed ID: 31017314
[TBL] [Abstract][Full Text] [Related]
13. Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early-stage luminal breast cancer.
van Steenhoven JEC; Kuijer A; Kornegoor R; van Leeuwen G; van Gorp J; van Dalen T; van Diest PJ
Histopathology; 2020 Oct; 77(4):579-587. PubMed ID: 32557844
[TBL] [Abstract][Full Text] [Related]
14. Improving Ki67 assessment concordance by the use of an artificial intelligence-empowered microscope: a multi-institutional ring study.
Cai L; Yan K; Bu H; Yue M; Dong P; Wang X; Li L; Tian K; Shen H; Zhang J; Shang J; Niu S; Han D; Ren C; Huang J; Han X; Yao J; Liu Y
Histopathology; 2021 Oct; 79(4):544-555. PubMed ID: 33840132
[TBL] [Abstract][Full Text] [Related]
15. Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer.
Horii R; Tsuda H; Masuda S; Sugita H; Togashi K; Ohno S; Akiyama F
Breast Cancer; 2020 Nov; 27(6):1058-1064. PubMed ID: 32440959
[TBL] [Abstract][Full Text] [Related]
16. Interlaboratory variability of Ki67 staining in breast cancer.
Focke CM; Bürger H; van Diest PJ; Finsterbusch K; Gläser D; Korsching E; Decker T;
Eur J Cancer; 2017 Oct; 84():219-227. PubMed ID: 28829990
[TBL] [Abstract][Full Text] [Related]
17. Good staining quality ensuring the reproducibility of Ki67 assessment.
Wang YH; Lai CR; Lien HC; Hsu CY
J Clin Pathol; 2020 Jul; 73(7):413-417. PubMed ID: 31796636
[TBL] [Abstract][Full Text] [Related]
18. Comparison between Ki67 labeling index determined using image analysis software with virtual slide system and that determined visually in breast cancer.
Maeda I; Abe K; Koizumi H; Nakajima C; Tajima S; Aoki H; Tsuchiya J; Tsuchiya S; Tsuchiya K; Shimo A; Tsugawa K; Ueno T; Tatsunami S; Takagi M
Breast Cancer; 2016 Sep; 23(5):745-51. PubMed ID: 26271611
[TBL] [Abstract][Full Text] [Related]
19. The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer.
Christgen M; von Ahsen S; Christgen H; Länger F; Kreipe H
Hum Pathol; 2015 Sep; 46(9):1341-9. PubMed ID: 26206765
[TBL] [Abstract][Full Text] [Related]
20. Reliability of the Ki67-Labelling Index in Core Needle Biopsies of Luminal Breast Cancers is Unaffected by Biopsy Volume.
Focke CM; Decker T; van Diest PJ
Ann Surg Oncol; 2017 May; 24(5):1251-1257. PubMed ID: 28008571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
